Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2017-09, Vol.31 (9), p.e418-e419
Hauptverfasser: Kitayama, N., Otsuka, A., Hamamoto, C., Kaku, Y., Shiragami, H., Okumura, Y., Tsujioka, K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e419
container_issue 9
container_start_page e418
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 31
creator Kitayama, N.
Otsuka, A.
Hamamoto, C.
Kaku, Y.
Shiragami, H.
Okumura, Y.
Tsujioka, K.
description
doi_str_mv 10.1111/jdv.14232
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_jdv_14232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JDV14232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2922-ef4a07dd6c90566cb5f39888e80d494d3babdc0ff2d459b2a31d17f9c54f461f3</originalsourceid><addsrcrecordid>eNp1kLtOwzAUQC0EoqUw8APIK0Nav5LaIyrlpQoYgDVy_KAuiRPFCVU2PoFv5EsIBNi4y5XuPTrDAeAYoynuZ7bRr1PMCCU7YIxZwiOKON0FYyRIEgkRixE4CGGDEMI45vtgRDjFgnA0Bve3Li8b51328fbuvG6V0bCS3jvV5q5xAToPZX9pnPEN3LpmDdW6Lvs_LDqTl8_Gl22AuWlfpCmcPAR7VubBHP3sCXi8WD4srqLV3eX14mwVKSIIiYxlEs21TpRAcZKoLLZUcM4NR5oJpmkmM62QtUSzWGREUqzx3AoVM8sSbOkEnA5eVZch1MamVe0KWXcpRulXlbSvkn5X6dmTga3arDD6j_zN0AOzAdi63HT_m9Kb86dB-QkK5W6K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Kitayama, N. ; Otsuka, A. ; Hamamoto, C. ; Kaku, Y. ; Shiragami, H. ; Okumura, Y. ; Tsujioka, K.</creator><creatorcontrib>Kitayama, N. ; Otsuka, A. ; Hamamoto, C. ; Kaku, Y. ; Shiragami, H. ; Okumura, Y. ; Tsujioka, K.</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.14232</identifier><identifier>PMID: 28319280</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Drug Eruptions - etiology ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Male ; Panniculitis - chemically induced ; Pyrimidines - adverse effects ; Pyrimidines - therapeutic use</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2017-09, Vol.31 (9), p.e418-e419</ispartof><rights>2017 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2922-ef4a07dd6c90566cb5f39888e80d494d3babdc0ff2d459b2a31d17f9c54f461f3</citedby><cites>FETCH-LOGICAL-c2922-ef4a07dd6c90566cb5f39888e80d494d3babdc0ff2d459b2a31d17f9c54f461f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.14232$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.14232$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28319280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kitayama, N.</creatorcontrib><creatorcontrib>Otsuka, A.</creatorcontrib><creatorcontrib>Hamamoto, C.</creatorcontrib><creatorcontrib>Kaku, Y.</creatorcontrib><creatorcontrib>Shiragami, H.</creatorcontrib><creatorcontrib>Okumura, Y.</creatorcontrib><creatorcontrib>Tsujioka, K.</creatorcontrib><title>Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Aged</subject><subject>Drug Eruptions - etiology</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Male</subject><subject>Panniculitis - chemically induced</subject><subject>Pyrimidines - adverse effects</subject><subject>Pyrimidines - therapeutic use</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAUQC0EoqUw8APIK0Nav5LaIyrlpQoYgDVy_KAuiRPFCVU2PoFv5EsIBNi4y5XuPTrDAeAYoynuZ7bRr1PMCCU7YIxZwiOKON0FYyRIEgkRixE4CGGDEMI45vtgRDjFgnA0Bve3Li8b51328fbuvG6V0bCS3jvV5q5xAToPZX9pnPEN3LpmDdW6Lvs_LDqTl8_Gl22AuWlfpCmcPAR7VubBHP3sCXi8WD4srqLV3eX14mwVKSIIiYxlEs21TpRAcZKoLLZUcM4NR5oJpmkmM62QtUSzWGREUqzx3AoVM8sSbOkEnA5eVZch1MamVe0KWXcpRulXlbSvkn5X6dmTga3arDD6j_zN0AOzAdi63HT_m9Kb86dB-QkK5W6K</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Kitayama, N.</creator><creator>Otsuka, A.</creator><creator>Hamamoto, C.</creator><creator>Kaku, Y.</creator><creator>Shiragami, H.</creator><creator>Okumura, Y.</creator><creator>Tsujioka, K.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia</title><author>Kitayama, N. ; Otsuka, A. ; Hamamoto, C. ; Kaku, Y. ; Shiragami, H. ; Okumura, Y. ; Tsujioka, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2922-ef4a07dd6c90566cb5f39888e80d494d3babdc0ff2d459b2a31d17f9c54f461f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Drug Eruptions - etiology</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Male</topic><topic>Panniculitis - chemically induced</topic><topic>Pyrimidines - adverse effects</topic><topic>Pyrimidines - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kitayama, N.</creatorcontrib><creatorcontrib>Otsuka, A.</creatorcontrib><creatorcontrib>Hamamoto, C.</creatorcontrib><creatorcontrib>Kaku, Y.</creatorcontrib><creatorcontrib>Shiragami, H.</creatorcontrib><creatorcontrib>Okumura, Y.</creatorcontrib><creatorcontrib>Tsujioka, K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kitayama, N.</au><au>Otsuka, A.</au><au>Hamamoto, C.</au><au>Kaku, Y.</au><au>Shiragami, H.</au><au>Okumura, Y.</au><au>Tsujioka, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2017-09</date><risdate>2017</risdate><volume>31</volume><issue>9</issue><spage>e418</spage><epage>e419</epage><pages>e418-e419</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pmid>28319280</pmid><doi>10.1111/jdv.14232</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2017-09, Vol.31 (9), p.e418-e419
issn 0926-9959
1468-3083
language eng
recordid cdi_crossref_primary_10_1111_jdv_14232
source MEDLINE; Wiley Online Library All Journals
subjects Aged
Drug Eruptions - etiology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Male
Panniculitis - chemically induced
Pyrimidines - adverse effects
Pyrimidines - therapeutic use
title Nilotinib‐induced panniculitis in a patient with chronic myelogenous leukaemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nilotinib%E2%80%90induced%20panniculitis%20in%20a%20patient%20with%20chronic%20myelogenous%20leukaemia&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Kitayama,%20N.&rft.date=2017-09&rft.volume=31&rft.issue=9&rft.spage=e418&rft.epage=e419&rft.pages=e418-e419&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.14232&rft_dat=%3Cwiley_cross%3EJDV14232%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28319280&rfr_iscdi=true